HIGHLIGHTS
- who: Report and collaborators from the Internal Medicine, Saint Michael's Medical Center, Newark, USA Internal Medicine, St. George's University School have published the research work: Review began 06/15/2022 Review ended 07/09/2022 Published 07/11/2022 © Copyright, in the Journal: (JOURNAL) of July/11,/2022
- what: HT changes the natural history and significantly affects the overall survival of patients with MZL.
SUMMARY
Marginal zone lymphoma (MZL) is a rare, slow-growing/indolent B cell lymphoid neoplasm accounting for 10.5% to 11.8% of all B . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.